Fundraising Fox

Sage Therapeutics

Cambridge, US · Founded 2010 · Delaware corporation · 1 known investors

BiotechHealthtech

Founders & leadership

BG
Barry GreeneExecutive
KI
Kimi IguchiExecutive
MC
Michael CloonanExecutive
AM
Anne Marie CookExecutive
SJ
Stephen J. KanesExecutive
JM
Jeffrey M. JonasExecutive
AR
Albert RobichaudNamed on SEC filing
EB
Elizabeth BarrettNamed on SEC filing
JF
James FratesNamed on SEC filing
GG
Geno GermanoNamed on SEC filing
GG
George GolumbeskiNamed on SEC filing
SPSteven Paul
Steven PaulinNamed on SEC filingVenture Partner at Third Rock Ventures; physician-scientist in neuroscience and CNS drug discovery

Investors · 1

Third Rock VenturesreportedBoston · $100K – $5Mvia Kevin Starr · board

Reported raises · per SEC filings

Form D private placements

$698M disclosed across 3 rounds · 2014–2020

▶$650MraisedJan 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Barry GreeneExecutive Officer, Director
  • Kimi IguchiExecutive Officer
  • Michael CloonanExecutive Officer
  • Anne Marie CookExecutive Officer
  • Stephen J. KanesExecutive Officer
  • Albert RobichaudExecutive Officer
  • Jeffrey M. JonasExecutive Officer, Director
  • Elizabeth BarrettDirector
  • James FratesDirector
  • Geno GermanoDirector
  • George GolumbeskiDirector
  • Steven PaulDirector
  • Kevin P. StarrDirector
  • Michael F. ColaDirector
Offering amount
$650M
Amount sold
$650M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38MraisedMar 2014 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven PaulDirector
  • Robert T. NelsenDirector
  • Kevin StarrDirector
  • Jeffery M. JonasExecutive Officer, Director
  • Kimi IguchiExecutive Officer
Offering amount
$38M
Amount sold
$38M
First sale
Mar 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedJan 2014 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven PaulDirector
  • Kimi IguchiExecutive Officer
  • Jeffery M. JonasExecutive Officer, Director
  • Robert T. NelsenDirector
  • Kevin StarrDirector
Offering amount
$20M
Amount sold
$10M
First sale
Jan 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Sage Therapeutics went on to found or lead other companies.

Steve PaulDirectorFounded Voyager Therapeutics, Inc. +1Jamil BegSenior Director, Business Development & Brand LeaderFounded Nido Biosciences +1Carlos LoyaDrug Discovery and Porfolio StrategyFounded Aldebaran Therapeutics

Frequently asked questions

Who are Sage Therapeutics's investors?
Sage Therapeutics's investors include Third Rock Ventures.
How much funding has Sage Therapeutics raised?
Sage Therapeutics has disclosed $698M raised across 3 rounds.
Where is Sage Therapeutics headquartered?
Sage Therapeutics is headquartered in Cambridge, US.